Parkinson Mortality Rate Was 72 per 100,000 in 2024 - Summary - MDSpire
Advertisement
Parkinson Mortality Rate Was 72 per 100,000 in 2024
The age-adjusted Parkinson disease death rate among US adults aged 65 years and older was 72.0 deaths per 100,000 standard population in 2024, lower than the 2021 rate, according to a National Center for Health Statistics Data Brief.
To report the mortality rate associated with Parkinson disease among US adults aged 65 years and older in 2024.
Approach:
Data Source: Analysis based on National Vital Statistics System mortality files accessed through the CDC’s Wide-ranging Online Data for Epidemiologic Research.
Mortality Coding: Deaths identified using International Classification of Diseases, 10th Revision codes G20 for Parkinson disease and G21 for secondary parkinsonism.
Statistical Methods: Age-adjusted death rates calculated using the direct method and the 2000 US standard population; trends evaluated using Joinpoint regression.
The report indicates a decline in the age-adjusted death rate from 2021 to 2024, although this decrease was not statistically significant.
Limitations:
Misclassification on death certificates may lead to underestimation of death rates, particularly among American Indian and Alaska Native non-Hispanic adults, potentially by as much as 34%.
The report does not evaluate reasons for state-level variation in death rates.
Findings are based on underlying-cause-of-death coding rather than diagnostic or clinical records.
Conclusion:
The findings highlight the mortality impact of Parkinson disease among older adults, with significant variations by sex, age, race, and state.
Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.